Circulating endothelin in cardiac operations: Influence of blood pressure and endotoxin

Annals of Thoracic Surgery

Volumn 61, Issue 3, 1996, Pages 904-908

  Te Velthuis, Henk ^a   Jansen, Piet G M ^b   Oudemans Van Straaten, Heleen M ^b   Van Kamp, Gerard J ^b   Sturk, Augueste ^b   Eijsman, León ^b   Wildevuur, Charles R H ^b  

^a CENTRAL LABORATORY   (Netherlands)

^b NONE

Author keywords

[No Author keywords available]

Indexed keywords

ENDOTHELIN; ENDOTOXIN;

ADULT; AGED; ARTERIAL PRESSURE; ARTICLE; BLOOD PRESSURE; CLINICAL ARTICLE; CORONARY ARTERY BYPASS GRAFT; CORONARY ARTERY DISEASE; ENDOTHELIUM CELL; HEART SURGERY; HUMAN; MALE; PRESSORECEPTOR; PRIORITY JOURNAL; VASOCONSTRICTION;

EID: 0029938973     PISSN: 00034975     EISSN: None     Source Type: Journal    
DOI: 10.1016/0003-4975(95)01187-0     Document Type: Article

References (31)

1. Yanagisawa M, Kurihara H, Kimura S, et al. A novel potent vasoconstrictor peptide produced by vascular endothelial cells. Nature 1988;332:411-5.
2. Yoshizawa T, Osamu S, Giaid A, et al. Endothelin: a novel peptide in the posterior pituitary system. Science 1989;247: 462-4.
3. Dubin D, Pratt RE, Cooke JP, Dzau VJ. Endothelin, a potent vasoconstrictor, is a vascular smooth muscle mitogen. J Vase Biol Med 1989;1:150-4.
4. Kaufman H, Oribe E, Oliver JA. Plasma endothelin during upright tilt: relevance for orthostatic hypotension? Lancet 1991;338:1542-5.
5. Moravec SC, Reynolds EE, Stewart RW, Bond M. Endothelin is a positive inotropic agent in human and rat heart in vivo. Biochem Biophys Res Commun 1989;159:14-8.
6. Shichiri M, Hirata Y, Ando K, et al. Postural change and volume expansion affect endothelin levels [Letter]. JAMA 1990;263:661.
7. Fyrquist F, Saijonmaa O, Metsarinne K, Tikkanen I, Rosenlof K, Tikkanen T. Raised plasma endothelin-1 concentration following cold pressor test. Biochem Biophys Res Commun 1990;169:217-21.
8. Zamora MR, O'Brien RF, Rutherford RB, Weil JV. Serum endothelin-1 concentrations and cold provocation in primary Raynaud's phenomenon. Lancet 1990;336:1144-7.
9. Yoshizumi M, Kurihara H, Sugiyama T, et al. Hemodynamic shear stress stimulates endothelin production by cultured endothelial cells. Biochem Biophys Res Commun 1989;161: 859-64.
10. Kourembanas S, Marsden PA, McQuillan L, Faller DV. Hypoxia induces gene expression and secretion in cultured human endothelium. J Clin Invest 1991;88:1054-7.
11. Sugiura M, Inagami T, Kon V. Endotoxin stimulates endothelin release in vivo and in vitro as determined by radioimmunoassay. Biochem Biophys Res Commun 1989;161: 1220-7.
12. Morel DR, Lacroix JS, Hemsen A, Steining DA, Pittet JF, Lundberg JM. Increased plasma and pulmonary lymph levels of endothelin during endotoxin shock. Eur J Pharmacol 1989;167:427-8.
13. Knothe CH, Boldt J, Ballesteros M, Dapper F, Hempelmann G. Endothelin plasma levels in old and young patients during open heart surgery: correlations to cardiopulmonary and endocrinology parameters. J Cardiovasc Pharmacol 1992;20:664-70.
14. Komai H, Adatia IT, Elliott MJ, de Levai MR, Haworth SG. Increased plasma levels of endothelin-1 after cardiopulmonary bypass in patients with pulmonary hypertension and congenital heart disease. J Thorac Cardiovasc Surg 1993;106: 473-8.
15. Jansen PGM, te Velthuis H, Oudemans-van Straaten H, et al. Perfusion-related factors of endotoxin release during cardiopulmonary bypass. Eur J Cardiothorac Surg 1994;8:125-9.
16. Jansen NJG, van Oeveren W, Gu YJ, van Vliet MH, Eijsman L, Wildevuur CRH. Endotoxin release and tumor necrosis factor formation during cardiopulmonary bypass. Ann Thorac Surg 1992;54:744-8.
17. Rocke DA, Gaffin SL, Wells MT, Koen Y, Brock-Utine JG. Endotoxemia associated with cardiopulmonary bypass. J Thorac Cardiovasc Surg 1987;93:832-7.
18. Andersen LW, Baek L, Degn H, Ledh J, Rasmussen JP. Presence of circulating endotoxins during cardiac operations. J Thorac Cardiovasc Surg 1987;93:115-9.
19. Martinez-Pellús AE, Merino P, Bru M, et al. Can selective digestive decontamination avoid the endotoxemia and cytokine activation promoted by cardiopulmonary bypass? Crit Care Med 1993;21:1684-91.
20. Morrison DC, Danner RL, Dinarello CA, et al. Bacterial endotoxins and pathogenesis of Gram-negative infections: current status and future direction. J Endotox Res 1994;1: 71-83.
21. Sturk A, Janssen ME, Muylaert FR, Joop K, Thomas LLM, ten Cate JW. Endotoxin testing in blood. Prog Clin Biol Res 1987;231:371-85.
22. Ohri SK, Somasundaram S, Koak Y, et al. The effect of intestinal hypoperfusion on intestinal absorption and permeability during cardiopulmonary bypass. Gastroenterology 1994;106:318-23.
23. Hynynen M, Saijonmaa O, Tikkanen I, Heinonen J, Fyhrquist F. Increased plasma endothelin immunoreactivity during cardiopulmonary bypass: a preliminary observation. J Thorac Cardiovasc Surg 1992;102:1024-5.
24. Yoshimoto S, Ishizaki Y, Mori A, Sasaki T, Takakura K, Murota S. The role of cerebral microvessel endothelium in regulation of cerebral blood flow through production of endothelin-1. J Cardiovasc Pharmacol 1991;17(Suppl 7): S260-3.
25. Ohri SK, Becket J, Brannan J, Keogh BE, Taylor KM. Effects of cardiopulmonary bypass on gut flow, oxygen utilization, and intramucosal pH. Ann Thorac Surg 1990;57:1193-9.
26. Fiddian Green RG, Baker S. Predictive value of stomach wall pH for complications after cardiac surgery operations: comparison with other monitoring. Crit Care Med 1987;15:153-6.
27. Andersen LW, Landow L, Beak L, Jansen E, Baker S. Association between gastric mucosal pH and splanchnic endotoxin in patients undergoing cardiopulmonary bypass. Crit Care Med 1993;21:210-7.
28. Miyauchi T, Tomobe Y, Shiba R, et al. Involvement of endothelin in regulation of human vascular tonus. Potent vasoconstrictor effect and existence in endothelial cells. Circulation 1990;81:1874-80.
29. Michida T, Kawano S, Masuda E, et al. Role of endothelin 1 in hemorhagic shock-induced gastric mucosal injury in rats. Gastroenterology 1994;106:988-93.
30. 2+ channel in vascular smooth muscle. Proc Natl Acad Sci USA 1989;86: 3915-8.
31. Kiowski W, Lüscher TF, Linder L, Bühler FR. Endothelin-1 induced vasoconstriction in man: reversal by calcium channel blockade but not by nitrovasodilators or endothelium-derived relaxing factor. Circulation 1991;83:469-75.